Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-05-19 @ 7:06 AM
Study NCT ID:
NCT06237205
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-01
First Post:
2024-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency
Sponsor:
Korea University Anam Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GAUSS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None